"Tuberculosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS.
| Descriptor ID |
D014376
|
| MeSH Number(s) |
C01.252.410.040.552.846
|
| Concept/Terms |
Tuberculosis- Tuberculosis
- Tuberculoses
- Koch's Disease
- Koch Disease
- Kochs Disease
- Mycobacterium tuberculosis Infection
- Infection, Mycobacterium tuberculosis
- Infections, Mycobacterium tuberculosis
- Mycobacterium tuberculosis Infections
|
Below are MeSH descriptors whose meaning is more general than "Tuberculosis".
Below are MeSH descriptors whose meaning is more specific than "Tuberculosis".
- Tuberculosis
- Latent Tuberculosis
- Peritonitis, Tuberculous
- Tuberculoma
- Tuberculosis, Avian
- Tuberculosis, Bovine
- Tuberculosis, Cardiovascular
- Tuberculosis, Central Nervous System
- Tuberculosis, Cutaneous
- Tuberculosis, Endocrine
- Tuberculosis, Gastrointestinal
- Tuberculosis, Hepatic
- Tuberculosis, Laryngeal
- Tuberculosis, Lymph Node
- Tuberculosis, Miliary
- Tuberculosis, Multidrug-Resistant
- Tuberculosis, Ocular
- Tuberculosis, Oral
- Tuberculosis, Osteoarticular
- Tuberculosis, Pleural
- Tuberculosis, Pulmonary
- Tuberculosis, Splenic
- Tuberculosis, Urogenital
This graph shows the total number of publications written about "Tuberculosis" by people in this website by year, and whether "Tuberculosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 3 | 0 | 3 |
| 2001 | 0 | 1 | 1 |
| 2003 | 4 | 0 | 4 |
| 2004 | 1 | 2 | 3 |
| 2005 | 1 | 0 | 1 |
| 2006 | 3 | 1 | 4 |
| 2007 | 2 | 1 | 3 |
| 2008 | 4 | 0 | 4 |
| 2009 | 3 | 0 | 3 |
| 2010 | 2 | 0 | 2 |
| 2011 | 1 | 2 | 3 |
| 2012 | 1 | 0 | 1 |
| 2013 | 3 | 0 | 3 |
| 2014 | 4 | 0 | 4 |
| 2015 | 7 | 0 | 7 |
| 2016 | 7 | 0 | 7 |
| 2017 | 3 | 1 | 4 |
| 2018 | 2 | 0 | 2 |
| 2019 | 2 | 0 | 2 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
| 2022 | 5 | 0 | 5 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Tuberculosis" by people in Profiles.
-
Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349). Clin Infect Dis. 2023 02 08; 76(3):e580-e589.
-
Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panel. Lancet HIV. 2022 11; 9(11):e791-e800.
-
Efavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose Rifapentine. Clin Infect Dis. 2022 09 10; 75(4):560-566.
-
CD44 receptor targeted nanoparticles augment immunity against tuberculosis in mice. J Control Release. 2022 09; 349:796-811.
-
A data driven policy to minimise the tuberculosis testing cost among healthcare workers. Int J Health Plann Manage. 2022 Sep; 37(5):2697-2709.
-
Four-Month Rifapentine Regimens for Tuberculosis. Reply. N Engl J Med. 2022 03 17; 386(11):1095-1096.
-
Decreased plasma rifapentine concentrations associated with AADAC single nucleotide polymorphism in adults with tuberculosis. J Antimicrob Chemother. 2021 02 11; 76(3):582-586.
-
Predictive value of TNF-a, IFN-?, and IL-10 for tuberculosis among recently exposed contacts in the United States and Canada. BMC Infect Dis. 2020 Jul 31; 20(1):553.
-
Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual patient data. Lancet Infect Dis. 2020 06; 20(6):742-752.
-
Algorithm-guided empirical tuberculosis treatment for people with advanced HIV (TB Fast Track): an open-label, cluster-randomised trial. Lancet HIV. 2020 01; 7(1):e27-e37.